NCT06603064

Brief Summary

Investigators are conducting this study to test if temporarily and non-invasively stimulating the brain will affect the emotional response to stress in healthy participants. Participants will perform a series of tasks while completing an MRI scan. After this, participants will be randomized to undergo transcranial magnetic stimulation (TMS) at two visits, undergoing active stimulation at one visit and undergoing 'sham' stimulation at another visit. Immediately following both stimulation sessions, participants will repeat the tasks during MRI scanning.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
38mo left

Started Apr 2025

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Apr 2025Jul 2029

First Submitted

Initial submission to the registry

September 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

April 9, 2025

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

3.2 years

First QC Date

September 16, 2024

Last Update Submit

May 1, 2026

Conditions

Keywords

stressemotiontranscranial magnetic stimulationTMSfunctional Magnetic Resonance ImagingfMRIneuromodulationcardiovascular

Outcome Measures

Primary Outcomes (7)

  • Dorsal anterior cingulate cortex activation to stress

    Blood-oxygen-level-dependent (BOLD) signal in a dorsal anterior cingulate cortex (dACC) region of interest mask extracted from the incongruent (stress) vs congruent (control) contrast.

    30-60 mins post-stimulation

  • Dorsal anterior cingulate cortex connectivity to stress

    Generalized psychophysiological interaction (gPPI) estimate reflecting stressor-evoked dorsal anterior cingulate cortex (dACC) functional connectivity to the anterior insula, amygdala, and periaqueductal gray.

    30-60 mins post-stimulation

  • Change in arousal during stress

    Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of arousal ("To what extent do you feel calm?" 1 - very calm, 9 - very aroused) following the psychological stressor task compared to a pre-stressor baseline.

    30-60 mins post-stimulation

  • Change in valence during stress

    Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of valence ("To what extent do you feel happy vs unhappy?" 1 - very unhappy, 9 - very unhappy) following the psychological stressor task compared to a pre-stressor baseline.

    30-60 mins post-stimulation

  • Change in perceived control during stress

    Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of perceived control ("To what extent do you feel in control?" 1 - very little control, 9 - very much control) following the psychological stressor task compared to a pre-stressor baseline.

    30-60 mins post-stimulation

  • Systolic blood pressure response to stress

    The difference in systolic blood pressure (in mmHg) obtained during the psychological stress task compared to a resting pre-stressor period.

    30-60 mins post-stimulation

  • Heart rate response to stress

    The difference in heart rate (in beats per minute) obtained during the psychological stress task compared to a resting pre-stressor period.

    30-60 mins post-stimulation

Secondary Outcomes (2)

  • Dorsal anterior cingulate cortex (dACC) resting cerebral blood flow (rCBF)

    30-60 mins post-stimulation

  • Positive and Negative Affect Schedule - Expanded Form (PANAS-X)

    30-60 mins post-stimulation

Study Arms (2)

Active then Sham

EXPERIMENTAL

In this arm, participants will first undergo active theta burst stimulation (cTBS) at the first visit and then undergo sham cTBS in the second visit.

Device: Active continuous theta burst stimulationDevice: Sham continuous theta burst stimulation

Sham then Active

EXPERIMENTAL

In this arm, participants will first undergo sham theta burst stimulation (cTBS) at the first visit and then undergo active cTBS in the second visit.

Device: Active continuous theta burst stimulationDevice: Sham continuous theta burst stimulation

Interventions

This intervention involves an active form of continuous theta burst stimulation (cTBS) that will be targeted to the dorsal anterior cingulate cortex based on neural navigation software. cTBS will be delivered in one session, lasting a few minutes, before participants complete additional testing.

Active then ShamSham then Active

This intervention involves an sham form of continuous theta burst stimulation (cTBS) that will be targeted to the dorsal anterior cingulate cortex based on neural navigation software. cTBS will be delivered in one session, lasting a few minutes, before participants complete additional testing.

Active then ShamSham then Active

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • e. A person who reports that he or she was once on a disallowed medication but has discontinued this medication for at least a month or longer and is otherwise eligible, is allowed to participate in the study.
  • Anyone reporting 35 or more alcoholic drinks in the last 7 days is excluded.
  • Anyone reporting consumption of 6 or more alcoholic drinks on 3 or more occasions in the past 7 days is excluded.
  • Anyone reporting use of illicit drugs on 7 or more days in the past 2 weeks is excluded.
  • Medical conditions:
  • Epilepsy or a history of seizures.
  • Self-reported prior heart attack, stroke, bypass surgery, angioplasty, congestive heart failure, arrhythmia (cardiac rhythm problems).
  • Severe hypertension (SBP/DBP \> 160/and/or \>100 mmHg)
  • Cancer (treatment in last 12 months, allowances for non-melanoma skin cancer)
  • Liver disease
  • Kidney disease
  • Type I diabetes
  • Self-reported history of a major neurological disorder or brain injury resulting in ongoing symptoms or cognitive impairment (e.g., multiple sclerosis, cerebral palsy, major head injury)
  • Self-reported chronic psychotic illness (schizophrenia, bipolar disorder)
  • Pregnant participants, or participants actively planning to become pregnant in the next 3 months, are excluded.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Thomas E Kraynak, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Thomas E Kraynak, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Participants, study staff, and the principal investigator will be blinded (masked) to participant assignment. The TMS coil to be used for this study is specifically designed to ensure participant and study staff blinding to condition.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This study will use a within-subject crossover design involving an \'active\' TMS arm and a \'sham\' (placebo) TMS arm. Each arm involves one visit (approx 2 hours each). Participants will complete both arms of the design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 19, 2024

Study Start

April 9, 2025

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2029

Last Updated

May 6, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

We will comply with all National Institute of Mental Health (NIMH) guidelines regarding data sharing and make use of NIMH databases.

Locations